Is there an anti-androgen withdrawal syndrome for enzalutamide?-Reference-Cited by-同舟云学术

Is there an anti-androgen withdrawal syndrome for enzalutamide?

Published:2014-04-02 Issue:5 Volume:32 Page:1171-1176
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

von Klot Christoph A. J.,Kramer Mario W.,Böker Alena,Herrmann Thomas R. W.,Peters Inga,Kuczyk Markus A.,Ligges Uwe,Gschwend Jürgen E.,Retz Margitta,Schmid Sebastian C.,Stenzl Arnulf,Schwentner Christian,Todenhöfer Tilmann,Stöckle Michael,Ohlmann Carsten-Henning,Azone Ines,Mager René,Bartsch Georg,Haferkamp Axel,Heidenreich Axel,Piper Charlotte,Merseburger Axel S.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-014-1288-3.pdf

Reference37 articles.

1. Scher HI, Kelly WK (1993) Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer. J Clin Oncol 11(8):1566–1572

2. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T et al (2013) EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol

3. Pond GR, Sonpavde G, de Wit R, Eisenberger MA, Tannock IF, Armstrong AJ (2014) The prognostic importance of metastatic site in men with metastatic castration-resistant prostate cancer. Eur Urol 65(1):3–6. doi: 10.1016/j.eururo.2013.09.024

4. Thomson D, Charnley N, Parikh O (2014) Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate-resistant prostate cancer. Eur J Cancer 50(5):1040–1041. doi: 10.1016/j.ejca.2013.12.017

5. Heidenreich A, Pfister D, Merseburger A, Bartsch G; German Working Group on Castration-Resistant Prostate Cancer (GWG-CRPC) (2013) Castration-resistant prostate cancer: where we stand in 2013 and what urologists should know. Eur Urol 64(2):260–265. doi: 10.1016/j.eururo.2013.05.021

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiandrogen Withdrawal Syndrome After Discontinuation of Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer: A Report of Two Clinical Cases and a Literature Review;Cureus;2024-06-30

2. Spontaneous Remission of Metastatic Castration-Resistant Prostate Cancer: Coley’s Toxin Revisited?;Cureus;2022-12-14

3. Second generation androgen receptor antagonists and challenges in prostate cancer treatment;Cell Death & Disease;2022-07-21

4. Androgen receptor signaling inhibitors: post-chemotherapy, pre-chemotherapy and now in castration-sensitive prostate cancer;Endocrine-Related Cancer;2021-08-01

5. PSA response to antiandrogen withdrawal: a systematic review and meta-analysis;Prostate Cancer and Prostatic Diseases;2021-02-18